Life expectancy of people who are dependent on opioids: A cohort study in New South Wales, Australia
- PMID: 32905957
- DOI: 10.1016/j.jpsychires.2020.08.013
Life expectancy of people who are dependent on opioids: A cohort study in New South Wales, Australia
Abstract
Background: People who are dependent on opioids have increased risk of premature death, but there are few estimates of life expectancy.
Methods: We calculated age-specific mortality rates in a cohort of people who had at least one prescription of an opioid agonist (methadone or buprenorphine) between 2001 and 2018 in New South Wales, Australia. We used life tables to estimate life expectancy at age 18. We also estimated the potential years of life lost before age 75, decomposed by cause of death.
Results: The cohort included 47,197 people, with a median of 9.8 years of follow-up. 5097 participants died, and the standardised mortality ratio (compared to the general population of New South Wales) was 6.06 (95% CI 5.90-6.23). Life expectancy at age 18 was an additional 47.5 years (95% CI 42.9-50.5) for men and 50.7 years (95% CI 45.4-54.8) for women; deficits of 14.7 and 15.8 years respectively when compared to the general population. The largest cause of death was non-communicable physical diseases, which accounted for 47% of deaths in life tables for men and 42% for women. Drug-related deaths accounted for 16% of deaths for men and 19% for women, but due to the young age at which these deaths occur, they contributed approximately one third of potential years of life lost.
Conclusion: In common with people with serious mental illnesses, people who are dependent on opioids have substantially reduced life expectancy. In both populations most excess deaths relate to non-communicable physical diseases.
Keywords: Epidemiology; Life expectancy; Mortality; Opioid-related disorders; Social marginalization; Substance-related disorders.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.Addiction. 2023 Aug;118(8):1527-1539. doi: 10.1111/add.16178. Epub 2023 Mar 20. Addiction. 2023. PMID: 36843415 Free PMC article.
-
Analysis using life tables of the major causes of death and the differences between country of birth groups in New South Wales, Australia.Public Health. 2009 May;123(5):351-7. doi: 10.1016/j.puhe.2009.03.006. Epub 2009 May 14. Public Health. 2009. PMID: 19443003
-
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582094 Free PMC article.
-
Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010.In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 3. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 3. PMID: 27227239 Free Books & Documents. Review.
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
Cited by
-
Causes of death among people who used illicit opioids in England, 2001-18: a matched cohort study.Lancet Public Health. 2022 Feb;7(2):e126-e135. doi: 10.1016/S2468-2667(21)00254-1. Epub 2021 Dec 11. Lancet Public Health. 2022. PMID: 34906332 Free PMC article.
-
Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001-22, New South Wales, Australia.Int J Epidemiol. 2025 Feb 16;54(2):dyaf037. doi: 10.1093/ije/dyaf037. Int J Epidemiol. 2025. PMID: 40187894 Free PMC article. No abstract available.
-
Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.Subst Abuse Treat Prev Policy. 2024 Mar 26;19(1):21. doi: 10.1186/s13011-024-00603-z. Subst Abuse Treat Prev Policy. 2024. PMID: 38532435 Free PMC article.
-
Metabolic Syndrome as a Risk Factor Among Lebanese Patients with Substance Use Disorder Undergoing Treatment for Recovery Through Rehabilitation or Opioid Substitution Treatment.Clin Pract. 2024 Dec 10;14(6):2661-2680. doi: 10.3390/clinpract14060210. Clin Pract. 2024. PMID: 39727798 Free PMC article.
-
Integrating an exercise program into opioid agonist therapy: a pilot study on feasibility, fitness improvements, and participation challenges.Addict Sci Clin Pract. 2025 Jul 8;20(1):52. doi: 10.1186/s13722-025-00583-w. Addict Sci Clin Pract. 2025. PMID: 40629478 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources